A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab

Future Oncology, Ahead of Print.

Source: Future Oncology - August 17, 2023 Category: Cancer & Oncology Authors: Alexander Spira Nicolas Girard Matthew Krebs Keunchil Park Catherine Shu Lindsay Dougherty Byoung Chul Cho Source Type: research